The US FDA approved Alaembic Pharma’s Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) in India. Patients with colon and rectal adenocarcinomas, breast adenocarcinomas, gastric adenocarcinomas, and pancreatic adenocarcinomas are treated with the injection. Fluorouracil Infusion has an expected market size of $5 million for a considerable length of time finishing December 2022, as indicated […]
Continue Reading
Zydus Lifesciences’ Acyclovir Cream, 5%, which is used to treat cold sores on the face and lips, received final approval from the United States Food and Drug Administration (FDA). Blisters known as cold sores are brought on by the herpes simplex virus. Acyclovir is a member of the antiviral class of drugs. The product will […]
Continue Reading
AstraZeneca India made its entry into the treatment of rare diseases in India on Tuesday. The company’s ‘Selumetinib’ for Indian patients has been approved by regulators. Regarding rare diseases, there is neither a precise estimation of the rate of mortality or morbidity in India nor an understanding of the disease burden on the public healthcare […]
Continue Reading
UK government has launched a publication of a brand-new Rare Diseases Action Plan for England, which will guarantee that people with these conditions will continue to receive support, equitable access to testing, and improved care and treatment. This builds on the first Rare Diseases Action Plan for England, which was released in 2022 and developed […]
Continue Reading
Reata Pharmaceuticals Inc.’s drug for the treatment of a rare genetic disorder that causes progressive damage to the nervous system was approved by the U.S. Food and Drug Administration (FDA), prompting its shares to rise nearly 160% after the opening bell. Skyclarys, Reata’s first approved product, is expected to sell for $400 million in the […]
Continue Reading
Granules India announced that its Abbreviated New Drug Application (ANDA) for Losartan Potassium Tablets USP, 25 mg, 50 mg, and 100 mg, received approval from the US Food and Drug Administration (FDA). Losartan Potassium is a bioequivalent to the reference recorded drug item (RLD), Cozaar Tablets of Organon LLC. The US Food and Drug Administration […]
Continue Reading
Brinton Pharmaceuticals Ltd. opened its Global Research and Development Centre in the UK, in an effort to expand internationally. UK MP, Nigel Huddleston said, he is delighted to be inaugurating this new facility in Runcorn, which will help their domestic healthcare sector and create highly-skilled jobs, as he unveiled the Global R&D Centre in Runcorn, […]
Continue Reading
The Indian regulatory body that falls under the Health Ministry of India, the Central Drug Standard Control Organization (CDSCO), has granted approval to the medical watch from Xplore Health called CardiacSense. The company said in a press release that CardiacSense is the only medical watch that has accuracy that is higher than the thresholds set […]
Continue Reading
On, February, 22, 2023, Moderna Inc. said that US regulators have given its experimental personalised mRNA skin cancer vaccine and Merck & Co.’s drug Keytruda the designation of breakthrough therapies as an additional treatment for high-risk patients. After the market closed Moderna shares rose 2.5% to $164. Based on data from a mid-stage drug study […]
Continue Reading
According to preliminary data released by the US Centers for Disease Control and Prevention (CDC), the flu vaccine has been 68% effective at preventing hospitalizations in children, but it has been less effective at protecting seniors this season. In one study, the vaccine was effective at preventing hospitalization for seniors by 35%, and in a […]
Continue Reading